BIVV020

· Bioverativ (a Sanofi company)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BIVV020, covering 2024-02-22 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) [Phase 2]